INCY Incyte Corp
Services-Commercial Physical & Biological Research · Nasdaq · SEC EDGAR official
Market Value*
$11.20B
Revenue (FY)
$5.14B 2025-12-31
Net Income (FY)
$1.29B
P/E (float-based)
8.7
American pharmaceutical company.
Services-Commercial Physical & Biological Research · Nasdaq · SEC EDGAR official
American pharmaceutical company.